These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Emerging role of capecitabine in gastric cancer. Comella P, Franco L, Casaretti R, de Portu S, Menditto E. Pharmacotherapy; 2009 Mar; 29(3):318-30. PubMed ID: 19249950 [Abstract] [Full Text] [Related]
27. Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature. Bar-Sela G, Haim N. Cancer Chemother Pharmacol; 2009 Apr; 63(5):779-82. PubMed ID: 18641989 [Abstract] [Full Text] [Related]
31. Cardiotoxicity of 5-fluorouracil and capecitabine in a pancreatic cancer patient with a novel mutation in the dihydropyrimidine dehydrogenase gene. Shahrokni A, Rajebi MR, Harold L, Saif MW. JOP; 2009 Mar 09; 10(2):215-20. PubMed ID: 19287123 [Abstract] [Full Text] [Related]
32. Inflammation of actinic keratoses during capecitabine therapy. Lewis KG, Lewis MD, Robinson-Bostom L, Pan TD. Arch Dermatol; 2004 Mar 09; 140(3):367-8. PubMed ID: 15023790 [No Abstract] [Full Text] [Related]
36. Hand-foot syndrome with scleroderma-like change induced by the oral capecitabine: a case report. Lee SD, Kim HJ, Hwang SJ, Kim YJ, Nam SH, Kim BS. Korean J Intern Med; 2007 Jun 09; 22(2):109-12. PubMed ID: 17616027 [Abstract] [Full Text] [Related]